1. Emphasize the impact of atherosclerotic risk factors in the pathophysiology of atrial fibrillation.

2. Discuss mechanisms of stroke and the limitations of current methods of risk stratification.

3. Highlight what is known and unknown about clinically silent and device-detected AF.


Session date: 
10/20/2017 - 12:00pm to 1:00pm CDT
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Bernard J. Gersh, M.B., Ch.B., D.Phil, F.R.C.P., M.A.C.C., Ph.D. (Hon Causa)